Published in Am J Med Genet on July 15, 1994
The fragile X syndrome. J Med Genet (1998) 2.00
Repeat-mediated genetic and epigenetic changes at the FMR1 locus in the Fragile X-related disorders. Front Genet (2014) 0.82
The transcription-coupled repair protein ERCC6/CSB also protects against repeat expansion in a mouse model of the fragile X premutation. Hum Mutat (2015) 0.82
45,X/46,XY mosaicism and fragile X syndrome. Am J Med Genet A (2003) 0.75
Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell (1991) 12.27
An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science (1992) 8.20
Synthesis of ribonucleic acid and protein in plasmid-containing minicells of Escherichia coli K-12. J Bacteriol (1971) 5.35
Triplet repeat mutations in human disease. Science (1992) 3.35
Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms. J Med Genet (2003) 3.25
Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science (1993) 2.75
Paracentric inversions in humans: a review of 446 paracentric inversions with presentation of 120 new cases. Am J Med Genet (1995) 2.39
Evidence of founder chromosomes in fragile X syndrome. Nat Genet (1992) 2.38
Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics. Am J Med Genet (1997) 2.19
Deletion of Huntington's disease-linked G8 (D4S10) locus in Wolf-Hirschhorn syndrome. Nature (1985) 2.19
Autism and maternally derived aberrations of chromosome 15q. Am J Med Genet (1998) 2.16
Deletion and amplification of the HGPRT locus in Chinese hamster cells. Mol Cell Biol (1983) 2.10
Molecular heterogeneity of the fragile X syndrome. Nucleic Acids Res (1991) 2.00
Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families, using dinucleotide repeat polymorphisms. Am J Hum Genet (1991) 1.93
A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases. Am J Hum Genet (1994) 1.84
Detection of submicroscopic deletions in band 17p13 in patients with the Miller-Dieker syndrome. Am J Hum Genet (1988) 1.83
Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands. J Med Genet (2009) 1.64
Characterization of transferable plasmids from Shigella flexneri 2a that confer resistance to trimethoprim, streptomycin, and sulfonamides. Plasmid (1986) 1.63
Vascular steal: the pathogenetic mechanism producing sirenomelia and associated defects of the viscera and soft tissues. Pediatrics (1986) 1.60
Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring. JAMA (1993) 1.58
Fragile X and autism: a multicenter survey. Am J Med Genet (1986) 1.56
Allan-Herndon syndrome. I. Clinical studies. Am J Hum Genet (1990) 1.50
Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome. Am J Hum Genet (1993) 1.47
Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy. Am J Hum Genet (1994) 1.46
Mutant chinese hamster cells with a thermosensitive hypoxanthine-guanine phosphoribosyltransferase. Cell (1975) 1.44
Prader-Willi syndrome and Robertsonian translocations involving chromosome 15. Clin Genet (1991) 1.39
Autism and macrocephaly. Lancet (1997) 1.33
Spectral karyotyping refines cytogenetic diagnostics of constitutional chromosomal abnormalities. Hum Genet (1997) 1.33
Conjugal deoxyribonucleic acid replication by Escherichia coli K-12: stimulation in dnaB(ts) donors by minicells. J Bacteriol (1973) 1.27
Renpenning syndrome comes into focus. Am J Med Genet A (2005) 1.15
Social gaze, social avoidance, and repetitive behavior in fragile X males: a controlled study. Am J Ment Retard (1988) 1.14
Improved molecular diagnostics for ornithine transcarbamylase deficiency. Am J Hum Genet (1991) 1.12
Further evidence for genetic heterogeneity in the fragile X syndrome. Hum Genet (1987) 1.10
Three-generation dominant transmission of the Silver-Russell syndrome. Am J Med Genet (1990) 1.10
Structural analysis of mutant and revertant forms of Chinese hamster hypoxanthine-guanine phosphoribosyltransferase. J Biol Chem (1981) 1.10
Discordance of muscular dystrophy in monozygotic female twins: evidence supporting asymmetric splitting of the inner cell mass in a manifesting carrier of Duchenne dystrophy. Am J Med Genet (1991) 1.10
Fluorescent multiplex linkage analysis and carrier detection for Duchenne/Becker muscular dystrophy. Am J Hum Genet (1992) 1.08
Identification, distribution, and sequence analysis of new insertion elements in Caulobacter crescentus. J Bacteriol (1990) 1.03
Myotonic dystrophy: tissue-specific effect of somatic CTG expansions on allele-specific DMAHP/SIX5 expression. Hum Mol Genet (1999) 1.02
Streptococcus mutans and Streptococcus sanguinis colonization correlated with caries experience in children. Caries Res (2008) 1.02
Brachmann-de Lange syndrome: diagnostic difficulties posed by the mild phenotype. Am J Med Genet (1993) 1.01
Mutations in JARID1C are associated with X-linked mental retardation, short stature and hyperreflexia. J Med Genet (2008) 1.01
Conjugal deoxyribonucleic acid replication by Escherichia coli K-12: effect of nalidixic acid. J Bacteriol (1973) 1.01
Microsatellite analysis reveals a high incidence of maternal cell contamination in 46,XX products of conception consisting of villi or a combination of villi and membranous material. Am J Obstet Gynecol (2001) 1.01
Inverted duplication of 8p: ten new patients and review of the literature. Am J Med Genet (1993) 0.99
Two sisters with a distal deletion at the Xq26/Xq27 interface: DNA studies indicate that the gene locus for factor IX is present. Hum Genet (1987) 0.98
A robotics-assisted procedure for large scale cystic fibrosis mutation analysis. Hum Mutat (1994) 0.97
Conjugal deoxyribonucleic acid replication by Excherichia coli K-12: effect of chloramphenicol and rifampin. J Bacteriol (1973) 0.97
Visual inspection of data revisited: Do the eyes still have it? Behav Anal (1998) 0.96
Fragile X syndrome: growth, development, and intellectual function. Am J Med Genet (1988) 0.95
Beclomethasone mania. Br J Psychiatry (1989) 0.94
Split foot and developmental retardation associated with a deletion of three microsatellite markers in 7q21.2-q22.1. Clin Genet (1995) 0.94
DNA methylation analysis with respect to prenatal diagnosis of the Angelman and Prader-Willi syndromes and imprinting. Prenat Diagn (2000) 0.93
Deletion of 16q with prolonged survival and unusual radiographic manifestations. Am J Med Genet (1990) 0.91
Disruption of the IL1RAPL1 gene associated with a pericentromeric inversion of the X chromosome in a patient with mental retardation and autism. Clin Genet (2007) 0.91
Quantitative measurement of single- and double-strand breakage of DNA in Escherichia coli by the antitumor antibiotics bleomycin and talisomycin. Antimicrob Agents Chemother (1985) 0.91
Fragile X syndrome: incidence, clinical and cytogenetic findings in the black and white populations of South Carolina. Am J Med Genet (1988) 0.91
Carrier testing in the fragile X syndrome: attitudes and opinions of obligate carriers. Am J Med Genet (1997) 0.91
A deletion in the long arm of chromosome 18 in a child with serum carnosinase deficiency. Pediatr Res (1997) 0.90
Deletion involving D15S113 in a mother and son without Angelman syndrome: refinement of the Angelman syndrome critical deletion region. Am J Med Genet (1995) 0.90
Mutations affecting the antigenic properties of hypoxanthine-guanine phosphoribosyl transferase in cultured Chinese hamster cells. Somatic Cell Genet (1977) 0.90
Longitudinal study of cognitive abilities and adaptive behavior levels in fragile X males: a prospective multicenter analysis. Am J Med Genet (1996) 0.89
No apparent involvement of the FMR1 gene in five patients with phenotypic manifestations of the fragile X syndrome. Am J Med Genet (1994) 0.89
Most Jacobsen syndrome deletion breakpoints occur distal to FRA11B. Am J Med Genet (1998) 0.88
Addditional features of the Aarskog syndrome. J Pediatr (1977) 0.88
Photochemical binding of anthracene and other aromatic hydrocarbons to deoxyribonucleic acid with attendant loss of tritium. J Chem Soc Perkin 1 (1973) 0.88
Reversion of a mutation affecting the molecular weight of HGPRT: intragenic suppression and localization of X-linked genes. Somatic Cell Genet (1980) 0.87
A single base alteration in the CGG repeat region of FMR1: possible effects on gene expression and phenotype. J Med Genet (2002) 0.87
Diagnosis of Duchenne and Becker muscular dystrophies by polymerase chain reaction. A multicenter study. JAMA (1992) 0.87
FMR1 gene and fragile X syndrome. Am J Med Genet (2000) 0.87
Toothbrush efficacy for plaque removal. Int J Dent Hyg (2014) 0.87
Down syndrome with biparental inheritance of der(14q21q) and maternally derived trisomy 21: confirmation by fluorescent in situ hybridization and microsatellite polymorphism analysis. Am J Med Genet (1997) 0.86
A transposon-like element in the deletion-prone region of the dystrophin gene. Genomics (1992) 0.86
Multiple meningiomas in a patient with constitutional ring chromosome 22. Am J Med Genet (1993) 0.86
Two patients with duplication of 17p11.2: the reciprocal of the Smith-Magenis syndrome deletion? Am J Med Genet (1996) 0.85
Greig cephalopolysyndactyly syndrome. Am J Dis Child (1979) 0.85
Establishment of new human prostatic cancer cell line (JCA-1). Urology (1990) 0.84
A simple VNTR-PCR method for detecting maternal cell contamination in prenatal diagnosis. Genet Test (1998) 0.84
Kallmann syndrome associated with complex chromosome rearrangement. Am J Med Genet (1993) 0.84
Fabry disease in a large Nova Scotia kindred: carrier detection using leucocyte alpha-galactosidase activity and an NcoI polymorphism detected by an alpha-galactosidase cDNA clone. J Med Genet (1991) 0.83
Loss of Harvey ras heterozygosity in oral squamous carcinoma. J Oral Pathol Med (1989) 0.83
9p monosomy in a patient with Gilles de la Tourette's syndrome. Neurology (1991) 0.83
Speech-language and the fragile X syndrome: initial findings. ASHA (1987) 0.83
Amplification versus mutation as a mechanism for reversion of an HGPRT mutation. Somat Cell Mol Genet (1984) 0.83
Vascular basis for neural tube defects: a hypothesis. Pediatrics (1987) 0.83
Southern transfer protocol for confirmation of Huntington disease. Clin Chem (1996) 0.83
Photoproducts from DNA pyrimidine bases and polycyclic aromatic hydrocarbons. Nucleic Acids Res (1977) 0.82
A transforming Kirsten ras oncogene in an oral squamous carcinoma. J Oral Pathol Med (1990) 0.82
Disruption of DMD and deletion of ACSL4 causing developmental delay, hypotonia, and multiple congenital anomalies. Cytogenet Genome Res (2006) 0.82
DNA from Guthrie spots for diagnosis of DMD by multiplex PCR. Biochem Med Metab Biol (1990) 0.82
Prenatal diagnosis of mosaicism for deletion 22q13.3. Prenat Diagn (2001) 0.81
Discordant expression of fetal hydantoin syndrome in heteropaternal dizygotic twins. N Engl J Med (1982) 0.81
Fragile X syndrome: a common etiology of mental retardation. Am J Ment Defic (1987) 0.81